These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3116918

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH.
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [Abstract] [Full Text] [Related]

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguti O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M.
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [Abstract] [Full Text] [Related]

  • 25. Postantibiotic effect of aminoglycosides on staphylococci.
    Isaksson B, Maller R, Nilsson LE, Nilsson M.
    J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
    [Abstract] [Full Text] [Related]

  • 26. The antimicrobial spectrum of Xeroform®.
    Barillo DJ, Barillo AR, Korn S, Lam K, Attar PS.
    Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ, Norden CW.
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [Abstract] [Full Text] [Related]

  • 28. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E, Van der Linden MP, Crokaert F, Glupczynski Y.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [Abstract] [Full Text] [Related]

  • 29. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Matsuda M, Tanimoto H, Nakata K, Nakamori Y, Kusano N.
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [Abstract] [Full Text] [Related]

  • 30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K, Terai T, Igari J, Inoue H, Nakadate T, Oguri T, Suwabe A, Obata R, Ikemoto H, Ohno I, Okada S, Hayashi K, Mori T, Nakano K, Arakawa M, Gejyo F, Igarashi K, Yokouchi H, Okada M, Ito A, Sumitomo M, Aoki N, Matsushima T, Niki Y, Kitamura N, Suga M, Suzuki Y, Karasawa Y, Tosaka M, Nakata K, Nakatani T, Kohno S, Tomono K, Miyazaki Y, Inagawa H, Hirakata Y, Aoki S, Matsuda J, Kudo K, Kobayashi N, Kinoshita T, Konosaki H, Nasu M, Nagai H, Kobayashi H, Kawai S, Takayasu S, Hiramatsu K, Nakano T.
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [Abstract] [Full Text] [Related]

  • 31. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
    Goldstein EJ, Citron DM.
    Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
    [Abstract] [Full Text] [Related]

  • 32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H, Takeda H, Kawai S, Watanabe T, Okazaki M, Shimada K, Nakano K, Yokouchi H, Ikemoto H, Mori T, Igari J, Oguri T, Yamamoto M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Gejyo F, Okada M, Aoki N, Kitamura N, Suzuki Y, Karasawa Y, Kudo K, Kobayashi N, Tanaka T, Sumitomo M, Matsushima T, Oka M, Niki Y, Suga M, Tosaka M, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Nasu M, Hiramatsu K, Oikawa S.
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
    Zinner SH, Klastersky J, Gaya H, Bernard C, Ryff JC.
    Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192
    [Abstract] [Full Text] [Related]

  • 34. [Gentamicin-susceptibility of various pathogens isolated from clinical materials].
    Kosakai N, Oguri T.
    Jpn J Antibiot; 1976 Mar; 29(3):229-37. PubMed ID: 5619
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK, Elliott AM, Cobbs CG.
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [Abstract] [Full Text] [Related]

  • 36. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.
    Reller LB, Stratton CW.
    J Infect Dis; 1977 Aug; 136(2):196-204. PubMed ID: 408424
    [No Abstract] [Full Text] [Related]

  • 39. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J, Zhou H, Cui ZC, Wang L, Luo PF, Ji SZ, Hu XY, Ma B, Wang GY, Zhu SH, Xia ZF.
    Zhonghua Shao Shang Za Zhi; 2018 Apr 20; 34(4):225-232. PubMed ID: 29690741
    [Abstract] [Full Text] [Related]

  • 40. Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
    Van der Auwera P, Klastersky J, Lagast H, Husson M.
    Antimicrob Agents Chemother; 1986 Jul 20; 30(1):122-6. PubMed ID: 3092729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.